[HTML][HTML] Evaluation of nephrotoxicity and ototoxicity following amikacin administration once daily or every 48 hours in neonates

A Endo, K Hanawa, A Nemoto, T Ishikawa, S Kazama… - Medicine, 2022 - journals.lww.com
The purpose of this study was to evaluate the effects of once daily (OD) or every 48 hours
(every-48-h) administration of amikacin (AMK) on renal function and ototoxicity in neonates …

The prevalence and pattern of pharmaceutical and excipient exposure in a neonatal unit in Slovenia

P Fister, S Urh, A Karner, M Krzan… - The Journal of Maternal …, 2015 - Taylor & Francis
Objective: Because of the restraints on conducting studies on pharmaceutical use in sick
newborns, many drugs are used off-label in this population. Moreover, industrially …

Neonatal pharmacotherapy: legal and regulatory issues

R Bax, P Tomasi - Neonatal Pharmacology and Nutrition Update, 2015 - karger.com
Off-label and unlicensed use of medicines is high in the paediatric population and
specifically high in neonatal/paediatric intensive settings with up to 90% of cases. This is …

[HTML][HTML] Utilización de medicamentos fuera de ficha técnica y sin licencia en una Unidad de Cuidados Intensivos Neonatales española

V Arocas Casañ, B Cabezuelo Escribano… - Farmacia …, 2017 - SciELO Espana
AROCAS CASAN, Vicente et al. Off-label and unlicensed drug use in a Spanish Neonatal
Intensive Care Unit. Farm Hosp.[online]. 2017, vol. 41, n. 3, pp. 371-381. ISSN 2171-8695 …

[HTML][HTML] Risk factors and prevalence of newborn hearing loss in a private health care system of Porto Velho, Northern Brazil

JS Oliveira, LB Rodrigues, FS Aurélio… - Revista Paulista de …, 2013 - SciELO Brasil
OBJECTIVE: To determine the prevalence of hearing loss and to analyze the results of
newborn hearing screening and audiological diagnosis in private health care systems …

[PDF][PDF] European study of neonatal exposure to excipients (ESNEE)

S Graham, M Turner - Infant, 2011 - infantjournal.co.uk
Excipients affect the safety, efficacy and quality of medicines particularly in neonates who
are a highly vulnerable group of patients. At present there is a lack of data about the impact …

Vestibular system in infants after systemic aminoglycoside therapy

O Zagólski - International journal of pediatric otorhinolaryngology, 2007 - Elsevier
OBJECTIVES: The ototoxic action of systemic therapy with aminoglycoside antibiotics
leading to the loss of inner ear hair cells is well recognized. The mitochondria-mediated …

Development and validation of a predictive tool for adverse drug reactions in neonates under intensive care

RW Leopoldino, DP Marques, LC Rocha… - British Journal of …, 2024 - Wiley Online Library
Aims Neonates hospitalized in neonatal intensive care units (NICUs) commonly experience
adverse drug reactions (ADRs). Thus, we aimed to develop and validate a tool for predicting …

Assessment of amikacin Induced Ototoxicity in a Neonatal ICU Setup-An experience from tertiary care Teaching Hospital in South India

S Dilip, P Bendapudi, R Bhaskaran… - Research Journal of …, 2020 - indianjournals.com
Objectives This study aimed to assess the prevalence of Amikacin induced ototoxicity in
neonates in a tertiary care hospital and to elucidate the possible risk factors. Design: A …

Review of drug utilization patterns in NICU s worldwide

N Krzyżaniak, I Pawłowska… - Journal of clinical …, 2016 - Wiley Online Library
What is known and objectives When considering acute care settings, such as the neonatal
intensive care unit (NICU), the inappropriate use of medicines poses a great risk to …